Developer docs
API playgroundTry for free, no card

Search company profiles

abbott china

Full company profile

uuid02m8tby

Namestring
abbott china
Legal namestring
雅培贸易(上海)有限公司
Websiteurl
abbott.com.cn
Company typeenum
Public
Founded yearint
1995
Descriptiontext

Abbott China (雅培中国) is the Chinese operating subsidiary of U.S.-listed Abbott Laboratories (NYSE: ABT), operating as 雅培贸易(上海)有限公司 (Abbott Trading (Shanghai) Co., Ltd.) with 5,001-10,000 employees. It distributes and markets a diversified healthcare portfolio across five core technology platforms: cardiovascular devices (coronary and peripheral vascular stents, pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy, structural heart closure devices, 3D mapping and ablation systems, remote monitoring); continuous glucose monitoring under the FreeStyle Libre brand spanning first-generation and FreeStyle Libre 2 personal sensors plus a hospital-grade CGM system; diagnostics including the i-STAT handheld blood analyzer, ID NOW rapid molecular platform, and clinical chemistry/immunochemistry assays; established pharmaceuticals covering hepatology, gastroenterology, cardiology, neurology, gynecology, respiratory and urology; and neuromodulation (Proclaim XR and Eon Mini spinal cord stimulators, Infinity deep brain stimulation system for Parkinson's disease, epilepsy, and essential tremor). A consumer nutrition franchise under Ensure and Glucerna brands rounds out the portfolio.

The company serves two primary end markets: institutional healthcare (hospitals, clinics, medical specialists across vascular surgery, cardiology, endocrinology, and neurology) and consumer patients with chronic conditions such as diabetes, requiring glucose monitoring and nutritional support. Abbott China operates a hybrid go-to-market combining a direct enterprise sales force serving hospitals and procurement systems, professional medical channel distribution for prescription pharmaceuticals, pharmacy and retail distribution for consumer nutrition and self-monitoring devices, and direct-to-consumer availability for products like FreeStyle Libre. Revenue is generated through hardware sales (devices and sensors) and product sales (pharmaceuticals and nutrition) priced via negotiated hospital procurement and pharmacy channels; specific pricing is not publicly disclosed. The subsidiary has been awarded 'Top Employer China' certification for 15 consecutive years through 2026, a marker of sustained operational presence, and continues to invest in medical education, disease awareness campaigns (notably the 2026 peripheral vascular health initiative with leading vascular surgeons), and recurring CIIE participation.

Short descriptiontext

Abbott China (雅培中国), a subsidiary of Abbott Laboratories (NYSE: ABT), distributes cardiovascular devices, FreeStyle Libre continuous glucose monitoring, diagnostics, established pharmaceuticals, and nutrition products to Chinese hospitals, medical specialists, and consumer patients via direct, pharmacy, and digital channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
Markets served

Serves global market

Keyword5 values
medical devices, clinical diagnostics, continuous glucose monitoring, nutritional supplements, cardiovascular devices
Industry4 codes
PRIMARYHLAHAFAL
Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHAHAE
Insulin Pen Needles, Syringes & Infusion Sets (Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYAFAFAFAJ
Medical & Clinical Nutrition Beverage Production (Oral Nutritional Supplements)
Agriculture & Food Production/Beverage Production/Functional & Nutritional Beverage Production (Energy, Sports, Fortified)
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
  • Pharmaceutical Preparation Manufacturing325412
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
  • Pharmaceutical Preparations2834
Product category
Medical Devices and Diagnostics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Devices and Diagnostics
TypeHardware Sales
Description

Revenue from cardiovascular devices (stents, pacemakers, structural heart), diagnostic equipment (laboratory systems, point-of-care), and neuromodulation implants sold to hospitals and healthcare providers.

abbott.com.cn
2Established Pharmaceuticals
TypeOne Time License
Description

Revenue from mature prescription pharmaceuticals covering digestive, cardiovascular, neurological, respiratory, gynecological, and hepatic therapeutic areas, distributed through medical and pharmacy channels.

abbott.com.cn
3Nutritional Products
TypeOne Time License
Description

Revenue from scientific nutrition products including complete nutrition supplements (Ensure), diabetes-specific nutrition (Glucerna), and specialized medical nutrition for various patient populations.

abbott.com.cn
4Consumer Self-Testing Products
TypeHardware Sales
Description

Revenue from consumer-facing products like FreeStyle Libre for personal blood glucose monitoring, sold through pharmacies and directly to consumers.

abbott.com.cn
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1FreeStyle Libre (辅理善瞬感)
Description

Continuous glucose monitoring system for diabetes management

abbott.com.cn
+4 more records
Core offering1 text field

Abbott China develops, manufactures, and distributes a diversified portfolio of medical devices (cardiovascular stents, pacemakers, ICDs, CRT devices, neuromodulation implants), in vitro and point-of-care diagnostic systems, established prescription pharmaceuticals across digestive, cardiovascular, neurological, respiratory, and hepatic therapeutic areas, and scientific/clinical nutritional products. It markets directly to hospitals and medical professionals through a professional sales force, and reaches consumers through retail pharmacies and direct channels for nutrition supplements (Ensure, Glucerna) and the FreeStyle Libre continuous glucose monitoring system.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • FreeStyle Libre has transformed glucose monitoring by eliminating routine finger pricks
+1 more record
Product overview1 text field

Abbott China operates as a diversified healthcare company organized across five major business segments: (1) Cardiovascular Technologies — covering coronary and peripheral vascular interventions, cardiac rhythm management (pacemakers, ICDs, leads), heart failure devices (CRT), structural heart (left atrial appendage closure, mechanical/bioprosthetic valves, annuloplasty rings), remote monitoring, and 3D cardiac mapping/ablation systems; (2) Diabetes Care — anchored by the FreeStyle Libre continuous glucose monitoring (CGM) platform comprising FreeStyle Libre 1 and 2 generations for personal use, plus hospital-grade CGM and blood/beta-ketone meters; (3) Diagnostics — spanning clinical chemistry/immunochemistry, hematology, molecular automation, point-of-care i-STAT, and rapid molecular ID NOW platforms; (4) Established Pharmaceuticals — covering digestive (Creon, Domperidone, otilonium bromide, lactulose), gynecological (Femoston, Duphaston), cardiovascular (fenofibrate, metoprolol, amiodarone, propafenone), neurological (Levomargin), respiratory (clarithromycin), urinary (terazosin), and hepatology (ademetionine/Transmetil) products; (5) Neuromodulation — featuring the Proclaim XR and Eon Mini implantable spinal cord stimulation (SCS) systems for chronic pain, and the Infinity deep brain stimulation (DBS) system for movement disorders (Parkinson's, tremor, epilepsy). The portfolio spans consumer-facing nutritional products (Ensure Complete, Glucerna SR) alongside professional medical devices and prescription pharmaceuticals.

Product and service12 records
1FreeStyle Libre 2 (雅培瞬感 2 代) Continuous Glucose Monitoring System
CategoryContinuous Glucose Monitoring
Description

Second-generation continuous glucose monitoring (CGM) system for personal use that enables patients to monitor glucose levels continuously without routine finger pricks, with real-time glucose readings and alarms transmitted via smartphone integration.

2FreeStyle Libre (雅培瞬感 1 代) Continuous Glucose Monitoring System
CategoryContinuous Glucose Monitoring
Description

First-generation continuous glucose monitoring system for personal use, providing ambulatory glucose monitoring with factory-calibrated sensor technology.

3Ensure Complete (雅培全安素)
CategoryClinical Nutrition
Description

Complete nutritional formula available in vanilla and wheat flavors, serving as a medical nutrition product and health foundation for recovery and daily nutritional supplementation.

4Glucerna SR (雅培益力佳SR)
CategoryClinical Nutrition
Description

Specialized nutrition product for individuals with elevated blood glucose, designed to help manage blood sugar as part of diabetes dietary management.

5Proclaim XR Recharge-free Implantable Spinal Cord Stimulator
CategoryNeuromodulation
Description

Rechargeable implantable spinal cord stimulation (SCS) system for the treatment of chronic pain and movement disorders, featuring a wireless platform and software integration for personalized therapy.

6Infinity Deep Brain Stimulation System (Infinity DBS)
CategoryNeuromodulation
Description

Deep brain stimulation system that delivers electrical pulses to specific brain targets controlling motor function for treatment of Parkinson's disease, epilepsy, and essential tremor. FDA approved for Parkinson's disease since 2002; uses a wireless platform and software for personalized treatment.

7Implantable Pacemakers, ICDs and Pacing Leads
CategoryCardiovascular Devices
Description

Implantable cardiac pacemakers, implantable cardioverter defibrillators (ICDs), and pacing leads for cardiac rhythm management and treatment of arrhythmias.

8Cardiac Resynchronization Therapy Devices (CRT-P / CRT-D)
CategoryCardiovascular Devices
Description

Cardiac resynchronization therapy devices including biventricular pacemakers (CRT-P) and CRT defibrillators (CRT-D) for the treatment of heart failure.

9i-STAT Point-of-Care Diagnostic System
CategoryIn Vitro Diagnostics
Description

Point-of-care diagnostic platform enabling rapid blood testing for a range of parameters at the bedside or in clinical settings.

10ID NOW Rapid Diagnostic System
CategoryIn Vitro Diagnostics
Description

Rapid molecular diagnostic platform for infectious disease testing with fast turnaround time.

11Transmetil (思美泰) Ademetionine 1,4-Butanedisulfonate
CategoryEstablished Pharmaceuticals
Description

Hepatology pharmaceutical product with mechanisms including hepatocyte membrane improvement, detoxification, antioxidant effects, and promotion of liver cell regeneration; available in injectable and enteric-coated tablet forms.

12Ensure (安素) Enteral Nutrition Powder (TP)
CategoryClinical Nutrition
Description

Enteral nutrition powder for oral or tube feeding in patients requiring nutritional support.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-24
Description

Abbott China partnered with leading vascular surgery experts nationwide for the '足够健康 脉向未来' (Healthy Feet, Future Pulse) peripheral vascular disease awareness campaign. The initiative, launched in Beijing on May 24, 2026, aims to raise public awareness about peripheral vascular disease and improve disease recognition and treatment standards.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Major competitor in the China diagnostics market, particularly in laboratory diagnostics, clinical chemistry, immunoassay, and point-of-care testing where Abbott's i-STAT, ID NOW, and immunochemistry platforms compete for the same hospital lab customers.

TypeDirect peer
Description

China subsidiary of Medtronic plc; directly competes with Abbott China across cardiovascular devices, cardiac rhythm management, neuromodulation (DBS and SCS), and diabetes care, addressing the same hospital customers and patient populations.

3MicroPort Scientific
TypeEmerging player
Description

Shanghai-headquartered medical device group directly competing with Abbott China in coronary and peripheral vascular stents, structural heart, and cardiac rhythm management, with strong local procurement advantages in China.

TypeEmerging player
Description

Leading Chinese medical device manufacturer competing with Abbott China in patient monitoring, in-vitro diagnostics, and increasingly in cardiovascular and life-science instruments, with growing domestic-preference advantage in hospital tenders.

TypeBroad incumbent
Description

Global medical device incumbent operating in China across surgical equipment, neurotechnology, and orthopedic/spine segments; comparable as a multinational device seller targeting the same hospital procurement channels as Abbott China.

TypeDirect peer
Description

Operates a China business directly competing with Abbott in interventional cardiology, structural heart, cardiac rhythm management, and peripheral vascular intervention products sold to the same hospital channel.

TypeDirect peer
Description

Operates a substantial China medical device business including diagnostic systems, biosciences, and medication delivery solutions, with overlap to Abbott in point-of-care diagnostics and clinical laboratory products.

TypeBroad incumbent
Description

Broad multinational healthcare technology player in China competing with Abbott across patient monitoring, diagnostic imaging, and connected care solutions sold into the same hospital networks.

TypeBroad incumbent
Description

Broad multinational healthcare incumbent in China with overlapping capabilities in cardiovascular intervention (Biosense Webster electrophysiology), surgical devices, orthopedics, and vision care — overlapping with several Abbott China franchises as part of a wider portfolio.

TypeDirect peer
Description

Leading diagnostics competitor in China with overlapping portfolios in clinical chemistry, immunoassays, molecular diagnostics, and centralized laboratory automation that compete head-to-head with Abbott's diagnostics business.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

abbott china

Medical Devices and Diagnosticsabbott.com.cn

Abbott China (雅培中国), a subsidiary of Abbott Laboratories (NYSE: ABT), distributes cardiovascular devices, FreeStyle Libre continuous glucose monitoring, diagnostics, established pharmaceuticals, and nutrition products to Chinese hospitals, medical specialists, and consumer patients via direct, pharmacy, and digital channels.

What abbott china does

Abbott China (雅培中国) is the Chinese operating subsidiary of U.S.-listed Abbott Laboratories (NYSE: ABT), operating as 雅培贸易(上海)有限公司 (Abbott Trading (Shanghai) Co., Ltd.) with 5,001-10,000 employees. It distributes and markets a diversified healthcare portfolio across five core technology platforms: cardiovascular devices (coronary and peripheral vascular stents, pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy, structural heart closure devices, 3D mapping and ablation systems, remote monitoring); continuous glucose monitoring under the FreeStyle Libre brand spanning first-generation and FreeStyle Libre 2 personal sensors plus a hospital-grade CGM system; diagnostics including the i-STAT handheld blood analyzer, ID NOW rapid molecular platform, and clinical chemistry/immunochemistry assays; established pharmaceuticals covering hepatology, gastroenterology, cardiology, neurology, gynecology, respiratory and urology; and neuromodulation (Proclaim XR and Eon Mini spinal cord stimulators, Infinity deep brain stimulation system for Parkinson's disease, epilepsy, and essential tremor). A consumer nutrition franchise under Ensure and Glucerna brands rounds out the portfolio.

The company serves two primary end markets: institutional healthcare (hospitals, clinics, medical specialists across vascular surgery, cardiology, endocrinology, and neurology) and consumer patients with chronic conditions such as diabetes, requiring glucose monitoring and nutritional support. Abbott China operates a hybrid go-to-market combining a direct enterprise sales force serving hospitals and procurement systems, professional medical channel distribution for prescription pharmaceuticals, pharmacy and retail distribution for consumer nutrition and self-monitoring devices, and direct-to-consumer availability for products like FreeStyle Libre. Revenue is generated through hardware sales (devices and sensors) and product sales (pharmaceuticals and nutrition) priced via negotiated hospital procurement and pharmacy channels; specific pricing is not publicly disclosed. The subsidiary has been awarded 'Top Employer China' certification for 15 consecutive years through 2026, a marker of sustained operational presence, and continues to invest in medical education, disease awareness campaigns (notably the 2026 peripheral vascular health initiative with leading vascular surgeons), and recurring CIIE participation.

abbott china firmographics

Firmographics
Name
abbott china
Legal name
雅培贸易(上海)有限公司
Website
https://abbott.com.cn
Company type
Public
Founded year
1995
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Abbott China (雅培中国), a subsidiary of Abbott Laboratories (NYSE: ABT), distributes cardiovascular devices, FreeStyle Libre continuous glucose monitoring, diagnostics, established pharmaceuticals, and nutrition products to Chinese hospitals, medical specialists, and consumer patients via direct, pharmacy, and digital channels.
Ownership category
akta.pro rank

abbott china industry classification

Industry
Product category
Medical Devices and Diagnostics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Pharmaceutical Preparation Manufacturing (325412)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAHAFAL
Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLAHAHAE
Insulin Pen Needles, Syringes & Infusion Sets (Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Diabetes Care Devices (CGM, Insulin Delivery)
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYAFAFAFAJ
Medical & Clinical Nutrition Beverage Production (Oral Nutritional Supplements)
Agriculture & Food Production/Beverage Production/Functional & Nutritional Beverage Production (Energy, Sports, Fortified)

Keywords

  • Medical devices
  • Clinical diagnostics
  • Continuous glucose monitoring
  • Nutritional supplements
  • Cardiovascular devices

abbott china business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Medical Devices and Diagnostics: Revenue from cardiovascular devices (stents, pacemakers, structural heart), diagnostic equipment (laboratory systems, point-of-care), and neuromodulation implants sold to hospitals and healthcare providers.
  2. Established Pharmaceuticals: Revenue from mature prescription pharmaceuticals covering digestive, cardiovascular, neurological, respiratory, gynecological, and hepatic therapeutic areas, distributed through medical and pharmacy channels.
  3. Nutritional Products: Revenue from scientific nutrition products including complete nutrition supplements (Ensure), diabetes-specific nutrition (Glucerna), and specialized medical nutrition for various patient populations.
  4. Consumer Self-Testing Products: Revenue from consumer-facing products like FreeStyle Libre for personal blood glucose monitoring, sold through pharmacies and directly to consumers.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

abbott china product offering

Product offering

Core offering

Abbott China develops, manufactures, and distributes a diversified portfolio of medical devices (cardiovascular stents, pacemakers, ICDs, CRT devices, neuromodulation implants), in vitro and point-of-care diagnostic systems, established prescription pharmaceuticals across digestive, cardiovascular, neurological, respiratory, and hepatic therapeutic areas, and scientific/clinical nutritional products. It markets directly to hospitals and medical professionals through a professional sales force, and reaches consumers through retail pharmacies and direct channels for nutrition supplements (Ensure, Glucerna) and the FreeStyle Libre continuous glucose monitoring system.

Product overview

Abbott China operates as a diversified healthcare company organized across five major business segments: (1) Cardiovascular Technologies — covering coronary and peripheral vascular interventions, cardiac rhythm management (pacemakers, ICDs, leads), heart failure devices (CRT), structural heart (left atrial appendage closure, mechanical/bioprosthetic valves, annuloplasty rings), remote monitoring, and 3D cardiac mapping/ablation systems; (2) Diabetes Care — anchored by the FreeStyle Libre continuous glucose monitoring (CGM) platform comprising FreeStyle Libre 1 and 2 generations for personal use, plus hospital-grade CGM and blood/beta-ketone meters; (3) Diagnostics — spanning clinical chemistry/immunochemistry, hematology, molecular automation, point-of-care i-STAT, and rapid molecular ID NOW platforms; (4) Established Pharmaceuticals — covering digestive (Creon, Domperidone, otilonium bromide, lactulose), gynecological (Femoston, Duphaston), cardiovascular (fenofibrate, metoprolol, amiodarone, propafenone), neurological (Levomargin), respiratory (clarithromycin), urinary (terazosin), and hepatology (ademetionine/Transmetil) products; (5) Neuromodulation — featuring the Proclaim XR and Eon Mini implantable spinal cord stimulation (SCS) systems for chronic pain, and the Infinity deep brain stimulation (DBS) system for movement disorders (Parkinson's, tremor, epilepsy). The portfolio spans consumer-facing nutritional products (Ensure Complete, Glucerna SR) alongside professional medical devices and prescription pharmaceuticals.

Differentiator

Problem solved

Functional benefit

Brands

  • FreeStyle Libre (辅理善瞬感): Continuous glucose monitoring system for diabetes management
  • Ensure (雅培全安素)
  • Glucerna (雅培益力佳)
  • Proclaim XR
  • Infinity DBS

Products and services

  • FreeStyle Libre 2 (雅培瞬感 2 代) Continuous Glucose Monitoring System Second-generation continuous glucose monitoring (CGM) system for personal use that enables patients to monitor glucose levels continuously without routine finger pricks, with real-time glucose readings and alarms transmitted via smartphone integration.
  • FreeStyle Libre (雅培瞬感 1 代) Continuous Glucose Monitoring System First-generation continuous glucose monitoring system for personal use, providing ambulatory glucose monitoring with factory-calibrated sensor technology.
  • Ensure Complete (雅培全安素) Complete nutritional formula available in vanilla and wheat flavors, serving as a medical nutrition product and health foundation for recovery and daily nutritional supplementation.
  • Glucerna SR (雅培益力佳SR) Specialized nutrition product for individuals with elevated blood glucose, designed to help manage blood sugar as part of diabetes dietary management.
  • Proclaim XR Recharge-free Implantable Spinal Cord Stimulator Rechargeable implantable spinal cord stimulation (SCS) system for the treatment of chronic pain and movement disorders, featuring a wireless platform and software integration for personalized therapy.
  • Infinity Deep Brain Stimulation System (Infinity DBS) Deep brain stimulation system that delivers electrical pulses to specific brain targets controlling motor function for treatment of Parkinson's disease, epilepsy, and essential tremor. FDA approved for Parkinson's disease since 2002; uses a wireless platform and software for personalized treatment.
  • Implantable Pacemakers, ICDs and Pacing Leads Implantable cardiac pacemakers, implantable cardioverter defibrillators (ICDs), and pacing leads for cardiac rhythm management and treatment of arrhythmias.
  • Cardiac Resynchronization Therapy Devices (CRT-P / CRT-D) Cardiac resynchronization therapy devices including biventricular pacemakers (CRT-P) and CRT defibrillators (CRT-D) for the treatment of heart failure.
  • i-STAT Point-of-Care Diagnostic System Point-of-care diagnostic platform enabling rapid blood testing for a range of parameters at the bedside or in clinical settings.
  • ID NOW Rapid Diagnostic System Rapid molecular diagnostic platform for infectious disease testing with fast turnaround time.
  • Transmetil (思美泰) Ademetionine 1,4-Butanedisulfonate Hepatology pharmaceutical product with mechanisms including hepatocyte membrane improvement, detoxification, antioxidant effects, and promotion of liver cell regeneration; available in injectable and enteric-coated tablet forms.
  • Ensure (安素) Enteral Nutrition Powder (TP) Enteral nutrition powder for oral or tube feeding in patients requiring nutritional support.

Quantifiable outcome

  • FreeStyle Libre has transformed glucose monitoring by eliminating routine finger pricks
  • +1 more outcomes

Companies that use abbott china

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

abbott china technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

abbott china partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Chinese Vascular Surgery Experts and SpecialistscoreStrategic or Co-development Partner · 24 May 2026Abbott China partnered with leading vascular surgery experts nationwide for the '足够健康 脉向未来' (Healthy Feet, Future Pulse) peripheral vascular disease awareness campaign. The initiative, launched in Beijing on May 24, 2026, aims to raise public awareness about peripheral vascular disease and improve disease recognition and treatment standards.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

abbott china competitors and assessment

Company assessment

Direct peers

  • Siemens Healthineers China: Major competitor in the China diagnostics market, particularly in laboratory diagnostics, clinical chemistry, immunoassay, and point-of-care testing where Abbott's i-STAT, ID NOW, and immunochemistry platforms compete for the same hospital lab customers.
  • Medtronic China: China subsidiary of Medtronic plc; directly competes with Abbott China across cardiovascular devices, cardiac rhythm management, neuromodulation (DBS and SCS), and diabetes care, addressing the same hospital customers and patient populations.
  • Boston Scientific China: Operates a China business directly competing with Abbott in interventional cardiology, structural heart, cardiac rhythm management, and peripheral vascular intervention products sold to the same hospital channel.
  • Becton Dickinson China: Operates a substantial China medical device business including diagnostic systems, biosciences, and medication delivery solutions, with overlap to Abbott in point-of-care diagnostics and clinical laboratory products.
  • Roche Diagnostics China: Leading diagnostics competitor in China with overlapping portfolios in clinical chemistry, immunoassays, molecular diagnostics, and centralized laboratory automation that compete head-to-head with Abbott's diagnostics business.

Emerging players

  • MicroPort Scientific: Shanghai-headquartered medical device group directly competing with Abbott China in coronary and peripheral vascular stents, structural heart, and cardiac rhythm management, with strong local procurement advantages in China.
  • Mindray: Leading Chinese medical device manufacturer competing with Abbott China in patient monitoring, in-vitro diagnostics, and increasingly in cardiovascular and life-science instruments, with growing domestic-preference advantage in hospital tenders.

Broad incumbents

  • Stryker China: Global medical device incumbent operating in China across surgical equipment, neurotechnology, and orthopedic/spine segments; comparable as a multinational device seller targeting the same hospital procurement channels as Abbott China.
  • Philips Healthcare China: Broad multinational healthcare technology player in China competing with Abbott across patient monitoring, diagnostic imaging, and connected care solutions sold into the same hospital networks.
  • Johnson & Johnson Medical China: Broad multinational healthcare incumbent in China with overlapping capabilities in cardiovascular intervention (Biosense Webster electrophysiology), surgical devices, orthopedics, and vision care — overlapping with several Abbott China franchises as part of a wider portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

abbott china social profiles

Digital presence

abbott china financial estimates

Financial estimate

Revenue estimate

Valuation estimate

abbott china leadership team

Management profile

Number of profiles

abbott china funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

abbott china M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about abbott china

What does abbott china do?

Abbott China develops, manufactures, and distributes a diversified portfolio of medical devices (cardiovascular stents, pacemakers, ICDs, CRT devices, neuromodulation implants), in vitro and point-of-care diagnostic systems, established prescription pharmaceuticals across digestive, cardiovascular, neurological, respiratory, and hepatic therapeutic areas, and scientific/clinical nutritional products. It markets directly to hospitals and medical professionals through a professional sales force, and reaches consumers through retail pharmacies and direct channels for nutrition supplements (Ensure, Glucerna) and the FreeStyle Libre continuous glucose monitoring system.

Is abbott china a public or private company?

abbott china is a public company. It is classified as corporate owned and is currently operating.

When was abbott china founded?

abbott china was founded in 1995. It employs 5,001 to 10,000 people.

How does abbott china make money?

Four revenue lines are on record. Medical Devices and Diagnostics are the primary driver. The others are established Pharmaceuticals, nutritional Products and consumer Self-Testing Products.

Who are abbott china's main competitors?

Direct peers on record are Siemens Healthineers China, Medtronic China, Boston Scientific China, Becton Dickinson China and Roche Diagnostics China. Emerging players are MicroPort Scientific and Mindray. Broad incumbents are Stryker China, Philips Healthcare China and Johnson & Johnson Medical China.

Does abbott china have an API?

No public API is recorded for abbott china.

What industry is abbott china in?

abbott china's product category is Medical Devices and Diagnostics. Its primary akta.pro industry code is HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation), with a secondary code of HLAHAHAE, Insulin Pen Needles, Syringes & Infusion Sets (Consumables). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales